NCT03932916View on ClinicalTrials.gov

Safety and Pharmacokinetic of Donepezil Pamoate in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

July 2, 2019

Primary Completion Date

August 6, 2020

Study Completion Date

September 11, 2020

Conditions
AD
Interventions
DRUG

Donepezil Pamoate for Injection 17mg

A dosage of 17mg HHT201 will be injected into the muscle in the gluteus once.

DRUG

Donepezil Pamoate for Injection 34mg

A dosage of 34mg HHT201 will be injected into the muscle in the gluteus once.

DRUG

Donepezil Hydrochloride 5mg

A tablet of 5mg Donepezil Hydrochloride will be administered once.

Trial Locations (1)

200030

Shanghai mental health center, Shanghai

All Listed Sponsors
lead

Shanghai Synergy Pharmaceutical Sciences Co., Ltd.

INDUSTRY

NCT03932916 - Safety and Pharmacokinetic of Donepezil Pamoate in Healthy Subjects | Biotech Hunter | Biotech Hunter